Considering the challenge of identifying secondary immune psychosis from PPD in clinical settings, NfL measure could support clinical algorithms in patients with FEP of unclear etiology by identifying patients who should receive CSF antibody testing. This evidence concerns the gene NEFL and psychotic disorder.